Carnitine palmitoyltransferase II deficiency, myopathic form (Q104470): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Verification Status | |||
Concluído | |||
| Property / Verification Status: Concluído / rank | |||
Normal rank | |||
Revision as of 10:19, 17 August 2026
The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_93488909 |
||
| English | Carnitine palmitoyltransferase II deficiency, myopathic form |
The myopathic form of carnitine palmitoyltransferase II (CPT II) deficiency, an inherited metabolic disorder that affects mitochondrial oxidation of long chain fatty acids (LCFA), is the most common and the least severe form of CPT II deficiency. The clinical manifestations are characterised by recurrent attacks of rhabdomyolysis, muscle pain, and weakness triggered usually by prolonged physical exercise and sometimes exacerbated by extremes in temperature; episodes may also be provoked or exacerbated by prolonged fasting, such as may occur with intercurrent viral illness. |
Statements
CID11:ID_93488909
0 references
dki-india-ID_93488909
0 references
Concluído
0 references
